Partners Agnes Juang, Ph.D., and Daniel A. Kamkar co-authored, “The Complex Litigation Surrounding Remicade And Its Biosimilar Challengers” which was published in Biosimilar Development.
Excerpt: Janssen Biotech Inc. and Celltrion Healthcare are engaged in a series of complex litigations over Janssen’s arthritis biologic medicine Remicade (infliximab) and Celltrion’s biosimilar.
Dr. Agnes Juang provides counsel and advice to innovators seeking to protect their inventions and to grow and monetize their IP assets. Her practice includes strategic global patent procurement, portfolio development...
Daniel A. Kamkar’s practice focuses on worldwide patent prosecution and portfolio management, patent infringement and validity analyses, freedom to operate analyses, USPTO proceedings, and general IP licensing. Daniel currently assists...
